Stephen Mahoney - Insider Trading & Ownership

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Summary
The estimated net worth of Stephen Mahoney is at least $207 K dollars as of November 1, 2023. Stephen Mahoney is the Title: Chief Financial and Operating Officer of Magenta Therapeutics, Inc. and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $207 K.
All Insider Reports
All Insider Reports

Ownership of Stephen Mahoney

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DNTH Dianthus Therapeutics, Inc. /DE/ Title: Chief Financial and Operating Officer $207 K Nov 30, 2022
VRDN Viridian Therapeutics, Inc.\DE President and CEO, Director Oct 30, 2023

Insider Transactions Reported by Stephen Mahoney:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership